Class III  -Tubulin Expression and Benefit from Adjuvant...

Clinical Cancer Research 2007 / 02 Vol. 13; Iss. 3

Class III  -Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non-Small Cell Lung Cancer: Analysis of NCIC JBR.10

Seve, P., Lai, R., Ding, K., Winton, T., Butts, C., Mackey, J., Dumontet, C., Dabbagh, L., Aviel-Ronen, S., Seymour, L., Whitehead, M., Tsao, M.-S., Shepherd, F. A., Reiman, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-06-1503
Date:
February, 2007
File:
PDF, 908 KB
english, 2007
Conversion to is in progress
Conversion to is failed